ABUS vs TER
Arbutus Biopharma Corp (ABUS) versus Teradyne Inc (TER) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported TER revenue for 2024-12-31 was $2.82B. Net income was $542.4M. Revenue was up 5.4% from 2023-12-31 to 2024-12-31. TER currently screens at market cap $63.96B and trailing P/E 75.7.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. TER currently screens at market cap $63.96B and trailing P/E 75.7.
Not investment advice. Open the ABUS and TER stock pages for the full models.
Not investment advice.